95 related articles for article (PubMed ID: 7619118)
1. Survival in chronic myeloid leukemia.
Malhotra H
J Assoc Physicians India; 1994 Apr; 42(4):345. PubMed ID: 7619118
[No Abstract] [Full Text] [Related]
2. [Chronic myelocytic leukemia in children].
Poliakov VE
Feldsher Akush; 1991 Nov; 56(11):23-9. PubMed ID: 1807975
[No Abstract] [Full Text] [Related]
3. Long duration priapism in blast crisis of chronic myeloid leukemia.
Dogra PN; Kumar P; Goel R; Dash SC
J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
[No Abstract] [Full Text] [Related]
4. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A
Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of blast crisis of chronic myeloid leukemia].
Kotlarek-Haus S
Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
[TBL] [Abstract][Full Text] [Related]
6. Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importance.
Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri NK; Kumar A; Saikia TK; Gopal R; Mazumdar AT; Advani SH
J Assoc Physicians India; 1988 Nov; 36(11):653-5. PubMed ID: 3248993
[No Abstract] [Full Text] [Related]
7. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
8. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
10. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
Sureda A; Carrasco M; de Miguel M; Martínez JA; Conde E; Sanz MA; Díaz-Mediavilla J; Sierra J
Haematologica; 2003 Nov; 88(11):1213-20. PubMed ID: 14607749
[TBL] [Abstract][Full Text] [Related]
11. Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
Trümper LH; Ho AD; Hunstein W; van der Lelie H; Goudsmit R
Blut; 1989 Feb; 58(2):85-7. PubMed ID: 2522015
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic granulocytic leukemia in blastic crisis.
Canellos GP
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
[No Abstract] [Full Text] [Related]
13. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM
Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of chronic myeloid leukemia].
Freund M
Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
[No Abstract] [Full Text] [Related]
15. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia.
Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H
Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186
[TBL] [Abstract][Full Text] [Related]
16. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
[TBL] [Abstract][Full Text] [Related]
18. Advances in prognosis of chronic myeloid leukemia.
Baccarani M; Russo D; Fanin R; Zuffa E; Tura S
Haematologica; 1992; 77(5):377-80. PubMed ID: 1483586
[No Abstract] [Full Text] [Related]
19. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib.
Fang B; Song Y; Han Z; Wei X; Lin Q; Zhu X; Yang R; Sun J; Tian G; Liu X; Cao G; Shi Y; Nie N; Li D; Zhao RC
Leuk Res; 2007 Oct; 31(10):1441-4. PubMed ID: 17383001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
